慢性鼻窦炎鼻窦特异性内镜鼻窦手术的最小影像学黏膜增厚或浑浊标准
系统综述检索Medline、Embase、Scopus和Web of Science数据库(从建库至2022年5月),初筛6070篇摘要,112项研究进入全文审查;未发现任何研究证明按鼻窦逐一评估的最小黏膜增厚或浑浊程度能预测该鼻窦的慢性鼻窦炎(CRS)或内镜鼻窦手术(ESS)后更优结局。作者认为ESS范围应通过考虑所有患者个体因素的个体化医疗决策确定。
要点
- 未发现证据支持最小毫米级黏膜增厚或鼻窦浑浊可预测鼻窦特异性CRS或ESS后更优结局。
- 初筛6070篇摘要,112项研究全文审查,均未提供上述预测证据。
- ESS范围应由考虑所有患者个体因素的个体化医疗决策确定。
核心结论
- 在药物治疗难治的CRS患者中,未找到证据支持最小毫米级黏膜增厚或鼻窦浑浊可作为鼻窦特异性CRS或ESS后更优结局的预测指标。
研究设计与样本
- 系统综述,遵循PRISMA指南;检索Medline、Embase、Scopus和Web of Science数据库,从建库至2022年5月。
主要发现
- 初筛6070篇摘要,112项研究进入全文审查;未发现任何研究调查或提供证据表明任何最小程度的影像学黏膜增厚或鼻窦浑浊能以鼻窦特异性方式预测CRS或ESS后更优结局。
临床怎么用
- 作者认为CRS的ESS范围应通过考虑所有患者个体因素的个体化医疗决策确定。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Primary chronic rhinosinusitis (CRS) is typically a diffuse process and the extent of endoscopic sinus surgery (ESS) performed for medically recalcitrant CRS is impacted by many factors. However, some third-party payors have implemented policies to authorize coverage for ESS in a sinus-by-sinus manner based on a minimal measurement of millimeters of mucosal thickening or sinus opacification in the corresponding sinus that is being surgically addressed. Our objective was to determine whether such policies are based on scientific evidence that in patients with medically recalcitrant CRS, a minimum measurement of mucosal thickening or sinus opacification is a predictor of CRS in that sinus or improved outcomes after ESS on a sinus-by-sinus basis. DATA SOURCES: Medline, Embase, Scopus, and Web of Science databases, from inception through May 2022. REVIEW METHODS: A systematic review was performed. The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines were followed. RESULTS: We identified 6070 abstracts which were screened and from which 112 studies ultimately underwent a full-text review. From these studies, we found that none investigated (or provided evidence of) whether any minimal degree of radiographic mucosal thickening or sinus opacification predicted CRS or better outcomes after ESS in a sinus-specific manner. CONCLUSION: We were unable to find evidence supporting a minimum millimeter measurement of mucosal thickening or sinus opacification as predictors of CRS or better post-ESS outcomes in a sinus-specific manner in patients with medically recalcitrant CRS. The extent of ESS for CRS should be determined through personalized medical decision-making that considers all patient-specific factors.
引用
- Walters ZA, Phillips KM, Previtera MJ, et al. Minimal Radiographic Mucosal Thickness or Opacification Criterion for Sinus-Specific Endoscopic Sinus Surgery for Chronic Rhinosinusitis. Otolaryngol Head Neck Surg. 2023. PMID: 36807128. doi:10.1002/ohn.297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。